多巴胺药物临床应用中国专家共识

2021-06-01 中国医师协会心血管内科医师分会 中华医学杂志2021,101(20):1503-1512.

多巴胺药物由于能够有效增加心输出量、提升血压和增加肾脏等内脏器官血流灌注,因此在我国临床上往往作为一线急救药物广泛应用于各种类型休克、心力衰竭以及急性肾损伤的治疗以及围手术期血压的维护。为帮助广大临床

中文标题:

多巴胺药物临床应用中国专家共识

发布日期:

2021-06-01

简要介绍:

多巴胺药物由于能够有效增加心输出量、提升血压和增加肾脏等内脏器官血流灌注,因此在我国临床上往往作为一线急救药物广泛应用于各种类型休克、心力衰竭以及急性肾损伤的治疗以及围手术期血压的维护。为帮助广大临床工作者合理、规范使用多巴胺,笔者根据国内外最新临床研究成果,参考相关指南,结合我国国情及临床实践,撰写本专家共识。对多巴胺的药理学特点、临床研究证据、适应证、临床使用方法以及药物不良反应等进行了全面的介绍。

相关资料下载:
[AttachmentFileName(sort=1, fileName=多巴胺药物临床应用中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c04801c0021212ce, title=多巴胺药物临床应用中国专家共识, enTitle=, guiderFrom=中华医学杂志2021,101(20):1503-1512., authorId=0, author=, summary=多巴胺药物由于能够有效增加心输出量、提升血压和增加肾脏等内脏器官血流灌注,因此在我国临床上往往作为一线急救药物广泛应用于各种类型休克、心力衰竭以及急性肾损伤的治疗以及围手术期血压的维护。为帮助广大临床, cover=https://img.medsci.cn/2021630/1625029884509_2020535.jpg, journalId=0, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jun 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>多巴胺药物由于能够有效增加心输出量、提升血压和增加肾脏等内脏器官血流灌注,因此在我国临床上往往作为一线急救药物广泛应用于各种类型休克、心力衰竭以及急性肾损伤的治疗以及围手术期血压的维护。为帮助广大临床工作者合理、规范使用多巴胺,笔者根据国内外最新临床研究成果,参考相关指南,结合我国国情及临床实践,撰写本专家共识。对多巴胺的药理学特点、临床研究证据、适应证、临床使用方法以及药物不良反应等进行了全面的介绍。</p> </div> </div> </div>, tagList=[TagDto(tagId=4445, tagName=多巴胺)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4445, guiderKeyword=多巴胺, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=21702, appHits=438, showAppHits=0, pcHits=715, showPcHits=21260, likes=3, shares=73, comments=40, approvalStatus=1, publishedTime=Wed Jun 30 23:53:41 CST 2021, publishedTimeString=2021-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 30 13:11:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 20:39:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=多巴胺药物临床应用中国专家共识.pdf)])
多巴胺药物临床应用中国专家共识.pdf
下载请点击:
评论区 (27)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193733, encodeId=38ad1193e33e5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Tue Feb 15 20:33:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180832, encodeId=33f1118083228, content=非常感谢~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdb72503183, createdName=天天, createdTime=Wed Jan 05 12:14:24 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083388, encodeId=65b6108338888, content=学些了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083387, encodeId=1d3a108338e36, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080567, encodeId=281a108056e06, content=谢谢好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:04:40 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2022-02-15 red咩

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193733, encodeId=38ad1193e33e5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Tue Feb 15 20:33:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180832, encodeId=33f1118083228, content=非常感谢~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdb72503183, createdName=天天, createdTime=Wed Jan 05 12:14:24 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083388, encodeId=65b6108338888, content=学些了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083387, encodeId=1d3a108338e36, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080567, encodeId=281a108056e06, content=谢谢好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:04:40 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2022-01-05 天天

    非常感谢~

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193733, encodeId=38ad1193e33e5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Tue Feb 15 20:33:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180832, encodeId=33f1118083228, content=非常感谢~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdb72503183, createdName=天天, createdTime=Wed Jan 05 12:14:24 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083388, encodeId=65b6108338888, content=学些了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083387, encodeId=1d3a108338e36, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080567, encodeId=281a108056e06, content=谢谢好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:04:40 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-23 一己怀

    学些了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1193733, encodeId=38ad1193e33e5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Tue Feb 15 20:33:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180832, encodeId=33f1118083228, content=非常感谢~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdb72503183, createdName=天天, createdTime=Wed Jan 05 12:14:24 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083388, encodeId=65b6108338888, content=学些了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083387, encodeId=1d3a108338e36, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080567, encodeId=281a108056e06, content=谢谢好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:04:40 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-23 一己怀

    谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1193733, encodeId=38ad1193e33e5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c942512147, createdName=red咩, createdTime=Tue Feb 15 20:33:09 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180832, encodeId=33f1118083228, content=非常感谢~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdb72503183, createdName=天天, createdTime=Wed Jan 05 12:14:24 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083388, encodeId=65b6108338888, content=学些了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:18 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083387, encodeId=1d3a108338e36, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 23 00:39:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080567, encodeId=281a108056e06, content=谢谢好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:04:40 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-16 龙珠

    谢谢好资料

    0